Profile picture

Professor Dania Mohty

King Faisal Specialist Hospital & Research Centre, Riyadh (Saudi Arabia)
Membership: HFA Member
Follow
Biography
Dania Mohty, MD, PhD is full professor of medicine and a consultant in cardiology She earned her medical degree from the University of Montpellier, France, and completed her fellowship in cardiovascular pathology at the University of Montpellier I. She completed 2 years of clinical and basic research fellowship at the Mayo Clinic, Rochester, MN, in the United States. She had a Master in Science in 2003. She also had a PhD in 2007 after completing 32 months at the cardiology institute, in Quebec, Canada. Pr Mohty has published more than 150 peer reviewed articles on many aspects of cardiology and echocardiography and is a recognized as an expert in echo imaging, valvular heart disease and cardiomyopathies; She has great interest in cardiac amyloidosis. She has more than 110 indexed publications in Pubmed. She is fluent in 3 languages French, English and Arabic, and is very often invited speaker at national and international conferences (more than 250 invitations).
Logo ESC

Contributor content

Models to predict unfavourable outcomes in heart failure
Session
Models to predict unfavourable outcomes in heart failure
2 September 2024
The taunt of moderate mixed/multiple valvular disease
Session
The taunt of moderate mixed/multiple valvular disease
28 August 2023
The burden, progression, and prognosis of calcific aortic stenosis
Session
The burden, progression, and prognosis of calcific aortic stenosis
25 August 2023
Epidemiology, prognosis, course, and outcome of valvular heart disease
Session
Epidemiology, prognosis, course, and outcome of valvular heart disease
29 August 2022
Multimodality imaging valvular heart disease
Session
Multimodality imaging valvular heart disease
9 December 2016
Asymptomatic valvular heart disease
Session
Asymptomatic valvular heart disease
8 December 2016
Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension
Session
Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension
30 August 2016

ESC 365 is supported by